- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Attention Deficit Disorder with Hyperactivity in United Kingdom
Total 1825 results
-
SunovionCompleted
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Tris Pharma, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Tufts Medical CenterCompletedAttention Deficit Hyperactivity DisorderUnited States
-
SunovionCompletedPediatric Attention Deficit Hyperactivity DisorderUnited States
-
State University of New York at BuffaloEli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
National Institute of Environmental Health Sciences...CompletedAttention-Deficit Hyperactivity DisorderUnited States
-
PfizerCompletedAttention Deficit Disorder With HyperactivityUnited States
-
Kimford Jay MeadorCompletedEpilepsy | Cognitive Deficits | Attention DeficitsUnited States
-
NYU Langone HealthCompletedAttention Deficit-HyperactivityUnited States
-
Akili Interactive Labs, Inc.CompletedAttention Deficit Disorder With HyperactivityUnited States
-
Rhodes Pharmaceuticals, L.P.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
University of CincinnatiNational Institute of Neurological Disorders and Stroke (NINDS)CompletedAttention Deficit Disorder With HyperactivityUnited States
-
National Institute of Mental Health (NIMH)CompletedAttention Deficit Disorder With Hyperactivity | Attention Deficit and Disruptive Behavior DisorderUnited States
-
Alcobra Ltd.CompletedADHD | Attention-Deficit/Hyperactivity Disorder, Predominantly Inattentive TypeUnited States, Israel
-
Children's Hospital Medical Center, CincinnatiRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Indiana UniversityNational Library of Medicine (NLM)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Hartford HospitalYale UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
ShireCompletedAttention Deficit Hyperactivity DisorderSpain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
-
Wake Forest University Health SciencesCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedAttention Deficit Disorder With HyperactivityUnited States
-
ShireTakeda Development Center Americas, Inc.RecruitingAttention Deficit Hyperactivity DisorderSpain, United States, United Kingdom, Belgium, Germany, Netherlands, Portugal, Austria, Sweden
-
ShireCompletedAttention Deficit Hyperactivity Disorder (ADHD)Germany, Italy, Poland, Spain, Romania, Belgium, Hungary, Netherlands, Sweden, United Kingdom
-
Alcobra Ltd.TerminatedAttention Deficit Hyperactivity Disorder (ADHD)United States, Israel
-
University of California, IrvineCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Oregon Health and Science UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Columbia UniversityCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Boston Children's HospitalNeuroscouting, L.L.C.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Boston Medical CenterCodman Square Health Center; Dorchester House Health CenterCompletedAttention Deficit/Hyperactivity DisorderUnited States
-
Cingulate TherapeuticsRho, Inc.CompletedADHD | Attention Deficit Hyperactivity Disorder | ADHD - Combined Type | Attention Deficit Hyperactivity Disorder CombinedUnited States
-
King's College LondonRecruitingCOVID-19 | Autism Spectrum Disorder | Attention Deficit Hyperactivity Disorder | Neurodevelopmental ConditionsUnited Kingdom
-
SunovionCompletedAdult Attention Deficit Hyperactivity DisorderUnited States
-
CephalonCompletedADHD | Attention Deficit/Hyperactivity DisorderUnited States
-
BRC Operations Pty. Ltd.UnknownAttention Deficit/Hyperactivity DisorderUnited States, Australia, Netherlands
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States, Australia, Belgium, Canada, France, Germany, Israel, Italy, Netherlands, Norway, Puerto Rico, South Africa, Sweden, United Kingdom
-
University of California, Los AngelesNeuroSigma, Inc.CompletedAttention-Deficit/Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Florida International UniversityUniversity of South Florida; Florida State University; Nova Southeastern UniversityRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
University of OklahomaRecruitingAttention Deficit Hyperactivity DisorderUnited States
-
Florida International UniversityCompleted
-
Massachusetts General HospitalSuspendedAttention Deficit Hyperactivity DisorderUnited States
-
University of ArizonaCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Children's Hospital Medical Center, CincinnatiNational Institute of Mental Health (NIMH)CompletedAttention Deficit Hyperactivity DisorderUnited States
-
Rhodes Pharmaceuticals, L.P.Purdue Pharma LPCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of ArizonaCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Eli Lilly and CompanyCompletedAttention Deficit Hyperactivity DisorderUnited States
-
Antonios LikourezosTerminatedAttention Deficit Hyperactivity DisorderUnited States
-
University of California, San FranciscoEnrolling by invitationAttention Deficit Hyperactivity DisorderUnited States
-
Targacept Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States